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Many pathogens can be transmitted via blood and blood
product, which is a big concern in transfusion medicine.
Focusing on the well-known tropical arbovirus infection, dengue
infection, the transmission via blood transmission is not com-
mon but it is already conﬁrmed for the possibility [1]. At present,
the great concern is on Zika virus, a new emerging pathogen that
is closely related to dengue virus [2]. The recent report from
Brazil on a possible case of transfusion transmitted Zika virus
infection [3] leads us to the new concern on the third possible
mode of transmission of this problematic virus (adding to
mosquito bite and sexual contact).
The safety of blood and blood product is the main concept in
transfusion practice [4]. The screening for the virus is the new
issue for discussion in the endemic area. In fact, in the
endemic tropical areas the high seropositive rate of Zika virus
can be observed. For example, in Cambodia, the recent report
showed that the seropositive rate was more than 50% [5].
However, there is still no report on the rate of viral
contamination. A recent report from South America has
mentioned the history screening for febrile illness but this is
usually problematic in transfusion medicine practice. For Zika
virus infection, asymptomatic infection is common and this
can be the big risk [6]. To estimate the risk of Zika virus
transmission via blood transmission is very interesting and can
be useful.
This can be done by mathematical modeling technique using
the data of case of similar problematic virus. Here, the authors
perform such study using the data on dengue virus in the pre-
vious study as model. In fact, the screening for dengue is per-
formed in many big blood bank in tropical Asia and the recent
report from India showed null prevalence [7]. However, that
study uses non-structural antigen (NS1) test as tool forscreening [7]. In a recent report, it is found that “NS1–Ag
detected 20% of all RNA conﬁrmed-positive donations” [8].
Hence, it can be assumed that there are 80% missed diagnosed
cases [8]. In a recent report from Brazil, Dias et al. used RNA
test for screening and found that 0.4% of healthy non-febrile
blood donor were positive for dengue RNA [9]. According to
Wikan et al. [10], 13 out of 17 dengue immonoreactive cases
have immunoreactive to Zika virus, which implies that 76.5%
of dengue positive case might be Zika virus positive. Also,
Wikan et al. [10] found that 13 out of 16 Zika virus
immonoreactive cases have immunoreactive to dengue virus,
which implies that if we ﬁnd common positive for Zika virus
in dengue virus positive case, the detected number of Zika
virus positive is only 81.3% of the actual number or 18.7% is
missed.
Using a mathematical principle and based on the described
data by Wikan et al. [10], we can assume that if there are 1000
dengue positive cases, there should be as many as 952 Zika virus
positive cases (765 common cases that can be detected by test
and 187 missed cases). Hence, the possible highest rate of
Zika virus positive in scenario of having dengue positive case
should be 95.2%. Based in the report from Brazil that 0.4% of
donated blood are positive for dengue virus, there can be up
to 0.384 8% for Zika virus. Hence, the calculated rate can be
the value to be mentioned for risk of Zika virus transmission
via blood transfusion. The observed rate is similar high to
dengue and this means it is apparently that blood transfusion
is a possible mode of Zika virus transmission and there is a
need to have a system to have a model laboratory screening
for Zika virus in blood bank.
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